PMID- 11411825 OWN - NLM STAT- MEDLINE DCOM- 20010628 LR - 20190901 IS - 0160-6689 (Print) IS - 0160-6689 (Linking) VI - 62 IP - 5 DP - 2001 May TI - Medication supervision and adherence of persons with psychotic disorders in residential treatment settings: a pilot study. PG - 394-9; quiz 400-1 AB - BACKGROUND: Little is known about risk factors for and predictors of medication nonadherence within residential facilities. This pilot study examined the association between medication adherence and level of supervision and other environmental and clinical variables among patients with schizophrenia and related psychotic disorders living in supported housing. METHOD: A convenience sample of 74 adult residents with schizophrenia and related psychotic disorders (DSM-IV criteria) living in 4 supported housing facilities in New York City were assessed by their treating psychiatrist for medication cessation during the previous month. Demographic characteristics, medications, supervision, global function as measured by the Global Assessment of Functioning (GAF), and substance abuse were also assessed. A priori hypotheses were that regimen complexity would be directly and medication supervision would be inversely related to medication nonadherence. RESULTS: In multivariate models, lack of direct medication supervision, negative medication attitude, and lower GAF score were associated with increased medication nonadherence in the recent past. CONCLUSION: This pilot study suggests that direct supervision of medication is associated with better adherence in residential treatment settings. This finding is relevant for mental health service planners and clinicians working in these settings. FAU - Grunebaum, M F AU - Grunebaum MF AD - Residential Community Service, St Luke's-Roosevelt Hospital, Brooklyn, NY, USA. mgrunebaum@neuron.cpmc.columbia.edu FAU - Weiden, P J AU - Weiden PJ FAU - Olfson, M AU - Olfson M LA - eng PT - Journal Article PL - United States TA - J Clin Psychiatry JT - The Journal of clinical psychiatry JID - 7801243 RN - 0 (Antipsychotic Agents) SB - IM EIN - J Clin Psychiatry 2001 Jun;62(6):480 MH - Adult MH - Antipsychotic Agents/administration & dosage/*therapeutic use MH - Attitude to Health MH - Cross-Sectional Studies MH - Female MH - Humans MH - Male MH - Middle Aged MH - Models, Statistical MH - Multivariate Analysis MH - Patient Care Management/statistics & numerical data MH - Patient Compliance MH - Pilot Projects MH - Psychiatric Status Rating Scales/statistics & numerical data MH - Psychotic Disorders/diagnosis/*drug therapy/psychology MH - Quality Assurance, Health Care/statistics & numerical data MH - Regression Analysis MH - *Residential Facilities/organization & administration MH - Risk Factors MH - Schizophrenia/diagnosis/drug therapy MH - Schizophrenic Psychology MH - Treatment Refusal EDAT- 2001/06/20 10:00 MHDA- 2001/06/29 10:01 CRDT- 2001/06/20 10:00 PHST- 2001/06/20 10:00 [pubmed] PHST- 2001/06/29 10:01 [medline] PHST- 2001/06/20 10:00 [entrez] AID - 10.4088/jcp.v62n0515 [doi] PST - ppublish SO - J Clin Psychiatry. 2001 May;62(5):394-9; quiz 400-1. doi: 10.4088/jcp.v62n0515.